Lanreotide Impurity 2 is a structurally related analogue arising during lanreotide synthesis or degradation pathways. Differences in side-chain composition or linking pattern subtly alter conformation and chromatographic behavior. Researchers characterize it to understand process-related modifications and stability. Applications include analytical-method qualification, impurity tracking, and peptide-structure comparison studies.
CAT No: Z10-101-194
CAS No:109605-17-6
Synonyms/Alias:(4R,7S,10S,13R,16S,19S)-13-((1H-Indol-3-yl)methyl)-19-((R)-2-acetamido-3-(naphthalen-2-yl)propanamido)-N-((2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl)-10-(4-aminobutyl)-16-(4-hydroxybenzyl)-7-isopropyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide;
Lanreotide Impurity 2 is a synthetic peptide derivative structurally related to the somatostatin analog lanreotide, commonly encountered as a process-related impurity or degradation product during peptide synthesis and formulation. As a well-characterized reference material, it holds significant value in the analytical and quality control domains of peptide-based pharmaceutical research. Its defined structure and close relationship to the parent compound make it an essential tool for laboratories focused on the development, characterization, and regulatory assessment of lanreotide and its analogs. The ability to accurately identify and quantify such impurities is crucial for ensuring the integrity, safety, and efficacy of peptide therapeutics, thereby underscoring the importance of Lanreotide Impurity 2 in both academic and industrial research settings.
Analytical method validation: Lanreotide Impurity 2 serves as a critical reference standard in the development and validation of analytical methods, particularly high-performance liquid chromatography (HPLC) and mass spectrometry (MS) protocols. By enabling the precise calibration and assessment of analytical systems, it helps researchers establish the sensitivity, specificity, and accuracy necessary for the reliable quantification of impurities in lanreotide formulations. This capability is fundamental for meeting stringent quality control requirements during drug substance and drug product manufacturing.
Peptide impurity profiling: The compound is instrumental in comprehensive impurity profiling studies, where its presence and concentration can be monitored as part of a broader effort to characterize the impurity landscape of peptide pharmaceuticals. Through comparative analyses, Lanreotide Impurity 2 aids in mapping degradation pathways, elucidating synthetic byproducts, and understanding the stability profile of lanreotide under various conditions. Such profiling is essential for defining acceptable impurity limits and supporting regulatory submissions.
Stability studies: In forced degradation and stability-indicating studies, the use of this impurity allows researchers to simulate and evaluate the chemical robustness of lanreotide formulations. By tracking the formation and behavior of Lanreotide Impurity 2 under stress conditions such as heat, light, or oxidative environments, scientists can gain critical insights into the degradation mechanisms and shelf-life of the active pharmaceutical ingredient. This information supports the optimization of formulation strategies and storage recommendations.
Peptide synthesis optimization: The occurrence and quantification of Lanreotide Impurity 2 provide valuable feedback during process development and scale-up of synthetic peptide manufacturing. By monitoring impurity levels at various stages of synthesis and purification, chemists can refine reaction conditions, reagent choices, and purification protocols to minimize impurity formation. Such process optimization is vital for achieving high-quality peptide products that meet rigorous industry standards.
Reference material for regulatory compliance: Laboratories engaged in the regulatory submission process utilize Lanreotide Impurity 2 as a well-defined reference material to demonstrate the capability of their analytical procedures to detect and quantify relevant impurities. Its use supports documentation and reporting requirements for impurity identification, qualification, and quantification, thereby facilitating compliance with international guidelines for the development and approval of peptide-based therapeutics.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More